Effect of Lactobacillus gasseri BNR17 on body fat reductio
- Conditions
- Not Applicable
- Registration Number
- KCT0000756
- Lead Sponsor
- Bioneer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
1) Voluntarily agree to participate and sign in informed consent form
2) Age: 20-65 years
3) BMI: 25kg/m2 = ~ = 35kg/m2
1) Subject who takes antiobesity drugs that affect body weight.
2) Subject who consumes probiotics within 2 weeks before the first visit.
3) Subject who cannot follow the dietary instruction during the study.
4) Subject who has following diseases:hypertension (=160/100mmHg), diabetes, hepatic dysfunction, renal dysfunction, hyperthyroidism or hypothyroidism, Cushing's syndrome, malignant tumors.
6) Subject who has an allergy to the ingredients of study product.
7) Subject who participated in another clinical trials within 4 weeks before the first visit.
8) Subject who is pregnant or bresat feeding.
9) Any condition that would make the subject unsuitable for enrollment in this study.
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method CT (Abdominal fat area: total fat area, visceral fat areat, subcutaneous fat area)
- Secondary Outcome Measures
Name Time Method DEXA (body fat mass, lean body mass, %body fat) ;Anthropometric measurements (body weight, BMI, waist circumference, hip circumference);Blood lipid profiles;Biomarkers of blood glucose;Blood inflammatory biomarkers